Boehringer Ingelheim: all 2,305 studies
Page 20 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive AdultsTerminatedNCT02182765Phase 1
- Observational Study of Meloxicam in Any Labeled IndicationCompletedNCT02182739
- Postmarketing Surveillance Study With MOBEC®CompletedNCT02182726
- Combivent vs. Salbutamol in Patients With Metacholine Induced BronchospasmCompletedNCT02182713Phase 4
- Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma CrisisTerminatedNCT02182700Phase 3
- A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182674Phase 2
- A Long-term Study of Ba253BINEB in Patients With Bronchial AsthmaCompletedNCT02182661Phase 3
- Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182635Phase 3
- Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182583Phase 3
- WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis PatientsCompletedNCT02182570Phase 3
- WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis PatientsCompletedNCT02182557Phase 3
- WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic RhinitisCompletedNCT02182544Phase 3
- Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy VolunteersCompletedNCT02182531Phase 1
- Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic RhinitisCompletedNCT02182518Phase 3
- Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With AsthmaCompletedNCT02182505Phase 3
- Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma PatientsCompletedNCT02182479Phase 3
- Single Rising Oral Doses of BI 10773 in Healthy Male VolunteersCompletedNCT02182453Phase 1
- Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy VolunteersCompletedNCT02182414Phase 1
- Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male VolunteersTerminatedNCT02182401Phase 1
- Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male SubjectsCompletedNCT02182388Phase 1
- Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy VolunteersCompletedNCT02182375Phase 1
- Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male SubjectsCompletedNCT02182362Phase 1
- Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male VolunteersCompletedNCT02182349Phase 1
- Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy VolunteersCompletedNCT02182336Phase 1
- Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male SubjectsCompletedNCT02182323Phase 1
- Assessment of the Effect of BI 201335 on the QT Interval in Healthy Female and Male SubjectsCompletedNCT02182310Phase 1
- Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male SubjectsCompletedNCT02182297Phase 1
- Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy VolunteersCompletedNCT02182284Phase 1
- Single Rising Dose Study of BI 201335 ZW in Healthy Male SubjectsTerminatedNCT02182271Phase 1
- Safety and Tolerability Study of BIBF 1120 as Intravenous Infusion and Absolute Bioavailability of BIBF 1120 as Soft Gelatine Capsule in Healthy SubjectsCompletedNCT02182258Phase 1
- Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological MalignanciesCompletedNCT02182245Phase 1
- A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung CancerCompletedNCT02182232Phase 1
- Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate CancerCompletedNCT02182219Phase 1
- An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid TumoursCompletedNCT02182206Phase 1
- Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male VolunteersCompletedNCT02182193Phase 1
- Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male VolunteersCompletedNCT02182154Phase 1
- An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT02182141Phase 1
- A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid TumoursCompletedNCT02182128Phase 1
- Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung CancerCompletedNCT02182102Phase 1
- Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male VolunteersCompletedNCT02182076Phase 1
- A Study With BIBF 1120 in Patients With Hormone Refractory Prostate CancerCompletedNCT02182063Phase 2
- Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung CancerCompletedNCT02182050Phase 2
- Safety, Pharmacodynamics, and Pharmacokinetics of BIBT 1011 BS in Healthy SubjectsCompletedNCT02182037Phase 1
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal ImpairmentCompletedNCT02182024Phase 1
- A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)CompletedNCT02182011Phase 3
- A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital SettingCompletedNCT02181998Phase 3
- Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)CompletedNCT02181985Phase 3
- Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact AdultsCompletedNCT02181972Phase 3
- Safety and Tolerability of Pharmaton Capsules in Healthy VolunteersCompletedNCT02181959Phase 2
- Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive PatientsCompletedNCT02181946Phase 4
- Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive WomenCompletedNCT02181933Phase 3
- Metamizol for the Treatment of Neoplastic Chronic PainTerminatedNCT02181920Phase 4
- Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy VolunteersCompletedNCT02181907Phase 1
- Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator TherapyCompletedNCT02181335Phase 3
- Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage RangeCompletedNCT02181322Phase 1
- Effect of Food on the Pharmacokinetics of Meloxicam in Healthy VolunteersCompletedNCT02181309Phase 1
- Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm SyndromeCompletedNCT02180516
- Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BSCompletedNCT02180503Phase 1
- Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy VolunteersCompletedNCT02180490Phase 1
- Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male VolunteersCompletedNCT02180477Phase 1
- Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring HemodialysisCompletedNCT02178306Phase 4
- Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine HydrochlorideCompletedNCT02178293Phase 4
- Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan MonotherapyCompletedNCT02177500Phase 3
- Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate HypertensionCompletedNCT02177487Phase 3
- Telmisartan Compared With Enalapril in Elderly Patients With Blood HypertensionCompletedNCT02177461Phase 4
- BIBR 277 Capsule in Patients With Essential HypertensionCompletedNCT02177448Phase 3
- Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate HypertensionCompletedNCT02177435Phase 3
- Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate HypertensionCompletedNCT02177422Phase 3
- Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate HypertensionCompletedNCT02177409Phase 3
- MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure MonitoringCompletedNCT02177396Phase 3
- Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial AsthmaTerminatedNCT02177370Phase 3
- Pramipexole in Untreated and Levodopa-treated Parkinson's Disease PatientsCompletedNCT02177357Phase 3
- Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177344Phase 3
- Lacidipine in Medical Practice in Patients With Mild to Moderate Essential HypertensionCompletedNCT02177331Phase 3
- Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177318
- Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male VolunteersCompletedNCT02177305Phase 1
- Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177253Phase 3
- Safety, Tolerability and Efficacy of Micardis® in Patients With Essential HypertensionCompletedNCT02176850
- Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02176564
- Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy SubjectsCompletedNCT02176512Phase 1
- Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate HypertensionCompletedNCT02176499Phase 3
- Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT02176200Phase 3
- Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary DiseaseTerminatedNCT02176187Phase 3
- Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal SubjectsCompletedNCT02175394Phase 1
- Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)CompletedNCT02175355Phase 3
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02175342Phase 2
- Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male SubjectsWithdrawnNCT02175238Phase 1
- Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed ConditionCompletedNCT02173795Phase 3
- Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02173782Phase 3
- BIBR 953 ZW in Healthy Elderly SubjectsCompletedNCT02173730Phase 1
- Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy VolunteersCompletedNCT02173717Phase 1
- Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)CompletedNCT02173691Phase 3
- Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female SubjectsCompletedNCT02173678Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male SubjectsCompletedNCT02173665Phase 1
- Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female VolunteersCompletedNCT02173652Phase 1
- Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female SubjectsCompletedNCT02173639Phase 1
- Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172807Phase 3
- Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172794Phase 3
- Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium TreatmentCompletedNCT02172781Phase 1
- Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive PatientsCompletedNCT02172586Phase 4